In light of an increase in cases of COVID-19 sub variant from 21.6% in February to 35.8% in March, India is seeing increasing trends of over 7800 COVID cases in a day.  

Covishield production was halted by the business in December 2021. 

CEO Adar Poonawalla announced on Wednesday that the company has resumed production of the COVID-19 vaccine Covishield. 

In response to rumours of a shortage of COVID-19 vaccines, he stated that although manufacturers have supplies on hand, there hasn't been any demand. 

Just as a precaution, they have restarted the manufacturing of the vaccine so that people have Covishield as a choice if they want it, said Mr. Poonawalla. 

He mentions that there are now 6 million booster doses of the Covovax vaccine available from the firm and urges individuals to get the booster shot.